332 related articles for article (PubMed ID: 35601800)
1. Practice guidance for the use of terlipressin for liver cirrhosis-related complications.
Qi X; Bai Z; Zhu Q; Cheng G; Chen Y; Dang X; Ding H; Han J; Han L; He Y; Ji F; Jin H; Li B; Li H; Li Y; Li Z; Liu B; Liu F; Liu L; Lin S; Ma D; Meng F; Qi R; Ren T; Shao L; Tang S; Tang Y; Teng Y; Wang C; Wang R; Wu Y; Xu X; Yang L; Yuan J; Yuan S; Yang Y; Zhao Q; Zhang W; Yang Y; Guo X; Xie W
Therap Adv Gastroenterol; 2022; 15():17562848221098253. PubMed ID: 35601800
[TBL] [Abstract][Full Text] [Related]
2. [Practice guidance for the use of terlipressin for liver cirrhosis-related complications (2021)].
;
Zhonghua Gan Zang Bing Za Zhi; 2022 Aug; 30(8):859-865. PubMed ID: 36207942
[TBL] [Abstract][Full Text] [Related]
3. Terlipressin has stood the test of time: Clinical overview in 2020 and future perspectives.
Kulkarni AV; Arab JP; Premkumar M; Benítez C; Tirumalige Ravikumar S; Kumar P; Sharma M; Reddy DN; Simonetto DA; Rao PN
Liver Int; 2020 Dec; 40(12):2888-2905. PubMed ID: 33065772
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome.
Krag A; Borup T; Møller S; Bendtsen F
Adv Ther; 2008 Nov; 25(11):1105-40. PubMed ID: 19018483
[TBL] [Abstract][Full Text] [Related]
5. Role of Terlipressin in Cirrhotic Patients with Ascites and without Hepatorenal Syndrome: A Systematic Review of Current Evidence.
Bai Z; An Y; Guo X; Teschke R; Méndez-Sánchez N; Li H; Qi X
Can J Gastroenterol Hepatol; 2020; 2020():5106958. PubMed ID: 32676484
[TBL] [Abstract][Full Text] [Related]
6. Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome.
Allegretti AS; Israelsen M; Krag A; Jovani M; Goldin AH; Schulman AR; Winter RW; Gluud LL
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD005162. PubMed ID: 29943803
[TBL] [Abstract][Full Text] [Related]
7. Functional magnetic resonance imaging-based assessment of terlipressin
Yan X; Shao R; Wang Y; Mao X; Lei J; Zhang L; Zheng J; Liu A; Zhao H; Gao F; Wang J; Li P; Yao S; Xu M; Xu J; Liu D; Mi Y; Gong X; Ye J; Deng M; Dang T; Ji J; Shao C; Liu C; Gu Y; Wu Y; Wang F; Teng G; Li X; Qi X; Ju S; Qi X
Ann Transl Med; 2019 Oct; 7(20):586. PubMed ID: 31807567
[TBL] [Abstract][Full Text] [Related]
8. Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1.
Boyer TD; Sanyal AJ; Wong F; Frederick RT; Lake JR; O'Leary JG; Ganger D; Jamil K; Pappas SC;
Gastroenterology; 2016 Jun; 150(7):1579-1589.e2. PubMed ID: 26896734
[TBL] [Abstract][Full Text] [Related]
9. Terlipressin May Decrease In-Hospital Mortality of Cirrhotic Patients with Acute Gastrointestinal Bleeding and Renal Dysfunction: A Retrospective Multicenter Observational Study.
Xu X; Liu B; Lin S; Li B; Wu Y; Li Y; Zhu Q; Yang Y; Tang S; Meng F; Chen Y; Yuan S; Shao L; Bernardi M; Yoshida EM; Qi X
Adv Ther; 2020 Oct; 37(10):4396-4413. PubMed ID: 32860184
[TBL] [Abstract][Full Text] [Related]
10. Recommendations on the Diagnosis and Initial Management of Acute Variceal Bleeding and Hepatorenal Syndrome in Patients with Cirrhosis.
Nevens F; Bittencourt PL; Coenraad MJ; Ding H; Hou MC; Laterre PF; Mendizabal M; Ortiz-Olvera NX; Vorobioff JD; Zhang W; Angeli P
Dig Dis Sci; 2019 Jun; 64(6):1419-1431. PubMed ID: 30684079
[TBL] [Abstract][Full Text] [Related]
11. [An evidence-based terlipressin therapy for gastroesophageal variceal hemorrhage].
Zhou XM; Qi XS; Jia JD
Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):245-248. PubMed ID: 29996332
[TBL] [Abstract][Full Text] [Related]
12. [Research progress of terlipressin in the treatment of cirrhotic ascites-related complications].
Liu CH; Xing F; Wang J
Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):929-932. PubMed ID: 31941255
[TBL] [Abstract][Full Text] [Related]
13. Complications of cirrhosis.
Rahimi RS; Rockey DC
Curr Opin Gastroenterol; 2012 May; 28(3):223-9. PubMed ID: 22343347
[TBL] [Abstract][Full Text] [Related]
14. Effect of terlipressin on renal function in cirrhotic patients with acute upper gastrointestinal bleeding.
Zhang J; Liu J; Wu Y; Romeiro FG; Levi Sandri GB; Zhou X; Li M; Qi X
Ann Transl Med; 2020 Mar; 8(6):340. PubMed ID: 32355784
[TBL] [Abstract][Full Text] [Related]
15. A study on clinical outcomes of combination of terlipressin and albumin in Hepatorenal Syndrome.
Krishna R; Raj J; Dev D; Prasad SC; Reghu R; V SO
Scand J Gastroenterol; 2020 Jul; 55(7):860-864. PubMed ID: 32634332
[TBL] [Abstract][Full Text] [Related]
16. Terlipressin and hepatorenal syndrome: what is important for nephrologists and hepatologists.
Magan AA; Khalil AA; Ahmed MH
World J Gastroenterol; 2010 Nov; 16(41):5139-47. PubMed ID: 21049548
[TBL] [Abstract][Full Text] [Related]
17. An Integrated Review of the Hepatorenal Syndrome.
Ojeda-Yuren AS; Cerda-Reyes E; Herrero-Maceda MR; Castro-Narro G; Piano S
Ann Hepatol; 2021; 22():100236. PubMed ID: 32846202
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and therapy of ascites in liver cirrhosis.
Biecker E
World J Gastroenterol; 2011 Mar; 17(10):1237-48. PubMed ID: 21455322
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of terlipressin and octreotide with variceal ligation for controlling acute esophageal variceal bleeding--a randomized prospective study].
Cho SB; Park KJ; Lee JS; Lee WS; Park CH; Joo YE; Kim HS; Choi SK; Rew JS; Kim SJ
Korean J Hepatol; 2006 Sep; 12(3):385-93. PubMed ID: 16998290
[TBL] [Abstract][Full Text] [Related]
20. Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial.
Lv Y; Yang Z; Liu L; Li K; He C; Wang Z; Bai W; Guo W; Yu T; Yuan X; Zhang H; Xie H; Yao L; Wang J; Li T; Wang Q; Chen H; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Niu J; Cai H; Xia J; Yin Z; Wu K; Fan D; Han G;
Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):587-598. PubMed ID: 31153882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
